How to Buy Iovance Biotherapeutics Stock
Iovance Biotherapeutics Inc
Iovance Biotherapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells.
Iovance Biotherapeutics stock last closed at $11.54, down 1.45% from the previous day, and has increased 109.44% in one year. It has overperformed other stocks in the Biotechnology industry by 1.33 percentage points. Iovance Biotherapeutics stock is currently +259.5% from its 52-week low of $3.21, and -37.04% from its 52-week high of $18.33.
There are currently 279.31M IOVA shares outstanding. The market cap of IOVA is $3.22B. In the past 24 hours, 3.38M IOVA shares were traded.
How to Buy Iovance Biotherapeutics Stock
Not sure how to invest in Iovance Biotherapeutics stock? Here's how.
- Figure out where to buy Iovance Biotherapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Iovance Biotherapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your method of payment and add your details.
- Evaluate Iovance Biotherapeutics stock: The Iovance Biotherapeutics ticker symbol is IOVA. Is Iovance Biotherapeutics stock a good investment? Should you buy shares of IOVA? How do IOVA's underlying business fundamentals look? Do top analysts think Iovance Biotherapeutics is a good buy? Why has IOVA's stock price moved recently? (Hint: Our stock research tools can help you evaluate if IOVA is a good stock to buy).
- Place your IOVA purchase: Decide if you will purchase IOVA shares at the current market price or use a limit order to purchase IOVA stock at a given price.
- Get key alerts regarding your IOVA position: Create a watchlist to the latest updates on your position in Iovance Biotherapeutics shares.
Step 1: Figure out where to buy Iovance Biotherapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy IOVA shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to buy IOVA stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new brokerage account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the stocks app, you need to deposit funds:
Watch the video below if you need help transferring funds into your brokerage account.
Step 4: Evaluate Iovance Biotherapeutics stock
After you have selected the best place to buy Iovance Biotherapeutics stock, it's crucial to evaluate their stock prior to buying, so you can understand the risk and upside.
Iovance Biotherapeutics Metrics
IOVA Overview
WallStreetZen was designed to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on IOVA's stock page.
What is the fair value of IOVA stock?
Analysts use many financial metrics, analyses, models, and charts to gauge IOVA's true value.
Using relative valuations metrics:
- IOVA may be undervalued based on its P/B ratio of 5.51x, relative to Biotechnology industry P/B ratio of 5.8x
You can access additional valuation analysis on IOVA's stock here.
IOVA Financial Health Overview
Passed Health Checks:
- IOVA has a low debt to equity ratio of 0.34.
- There are more short-term assets than long-term liabilities on the IOVA balance sheet.
- There are more short-term assets than short-term liabilities on the IOVA balance sheet.
Failed Health Checks:
- IOVA has $346.30M in cash and short term investments. This is not enough to cover its annual cash burn of $384.11M.
- Total IOVA debt is higher than 5 years ago, relative to shareholder equity.
- IOVA has cash burn of 384110000. It does not have sufficient cash and short-term investments to cover this.
- IOVA profit margin has gone down from N/A to -37,345.4% in the past year.
Is it a good time to buy Iovance Biotherapeutics stock, according to analysts?
Out of 8 Equities analysts who research IOVA, the consensus analyst rating on IOVA is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent IOVA Analyst Ratings
Peter Lawson, a top 24% analyst from Barclays maintains IOVA with a strong buy rating and raises their IOVA price target from $18.00 to $22.00, on Feb 29, 2024.
Reni Benjamin, a top 10% analyst from JMP Securities maintains IOVA with a buy rating and raises their IOVA price target from $18.00 to $25.00, on Feb 20, 2024.
JMP Securities's Reni Benjamin raised their price target on Iovance Biotherapeutics (NASDAQ: IOVA) by 38.9% from $18 to $25 on 2024/02/20. The analyst maintained their Buy rating on the stock.
On 2024/02/14, Iovance Biotherapeutics announced the FDA's accelerated approval of Amtagvi for use as a treatment for unresectable or metastatic melanoma previously treated with anti-PD-1 therapy, the analyst reported.
That was "great news" for shareholders considering that a commercial launch is on the way, Benjamin said, terming the stock a "unique investment opportunity, even in the face of the recent rally."
Geulah Livshits, a top 6% analyst from Chardan Capital maintains IOVA with a strong buy rating and raises their IOVA price target from $29.00 to $34.00, on Feb 20, 2024.
You can dig deeper into what analysts are saying on the Iovance Biotherapeutics stock forecast page.
IOVA Momentum
Are IOVA executives and large shareholders buying or selling the stock?
In the last 12 months, executives and large shareholders at IOVA have bought more shares than they have sold.
Igor Bilinsky, Chief Operating Officer of IOVA, was the latest IOVA insider to sell. They sold $16,967.03 worth of IOVA shares on Apr 15, 2024.
Dig into more about who owns IOVA stock here.
Does IOVA stock generate passive income?
No, Iovance Biotherapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your IOVA purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need more assistance buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your IOVA position
Now that you own some IOVA stock, you'll want to keep up with your new company.
Start a watchlist to track your IOVA stock.
IOVA Feed
How to Buy Stock in Iovance Biotherapeutics
To reiterate, here are the 6 steps you need to take to buy Iovance Biotherapeutics stock right now:
- Figure out where to buy Iovance Biotherapeutics stock
- Open a brokerage account
- Deposit funds into your investment account
- Evaluate Iovance Biotherapeutics stock
- Place your IOVA purchase
- Get key alerts regarding your IOVA position
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Iovance Biotherapeutics, add IOVA to your watchlist by clicking the button below.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.